Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
AUTOR(ES)
Wohlreich, Madelaine M
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=544561Documentos Relacionados
- A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
- Cardiac surgery for patients aged 65 years and older: a long term survival analysis.
- Cardiac surgery for patients aged 65 years and older: a long term survival analysis
- Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
- Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study